CHTF8
gene geneOn this page
Also known as FLJ20400CTF8
Summary
CHTF8 (chromosome transmission fidelity factor 8, HGNC:24353) is a protein-coding gene on chromosome 16q22.1, encoding Chromosome transmission fidelity protein 8 homolog (P0CG13). Chromosome cohesion factor involved in sister chromatid cohesion and fidelity of chromosome transmission. It is a selective cancer dependency (DepMap: 57.0% of cell lines).
This gene encodes a short protein that forms part of the Ctf18 replication factor C (RFC) complex that occurs in both yeast and mammals. The heteroheptameric RFC complex plays a role in sister chromatid cohesion and may load the replication clamp PCNA (proliferating cell nuclear antigen) onto DNA during DNA replication and repair. This gene is ubiquitously expressed and has been shown to have reduced expression in renal and prostate tumors. Alternatively spliced transcript variants have been described. This gene has a pseudogene on chromosome X.
Source: NCBI Gene 54921 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 23 total
- Cancer dependency (DepMap): dependent in 57.0% of screened cell lines
- MANE Select transcript:
NM_001039690
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:24353 |
| Approved symbol | CHTF8 |
| Name | chromosome transmission fidelity factor 8 |
| Location | 16q22.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ20400, CTF8 |
| Ensembl gene | ENSG00000168802 |
| Ensembl biotype | protein_coding |
| OMIM | 613202 |
| Entrez | 54921 |
Gene structure
Transcript identifiers
Ensembl transcripts: 8 — 5 protein_coding, 2 protein_coding_CDS_not_defined, 1 nonsense_mediated_decay
ENST00000398235, ENST00000448552, ENST00000518041, ENST00000519534, ENST00000522091, ENST00000522497, ENST00000523421, ENST00000567763
RefSeq mRNA: 2 — MANE Select: NM_001039690
NM_001039690, NM_001040146
CCDS: CCDS42185
Canonical transcript exons
ENST00000448552 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002091863 | 69132484 | 69132588 |
| ENSE00003546695 | 69118010 | 69120649 |
| ENSE00003681057 | 69121053 | 69121170 |
| ENSE00003849322 | 69121436 | 69121493 |
Expression profiles
Bgee: expression breadth ubiquitous, 134 present calls, max score 95.03.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 51.5794 / max 263.1907, expressed in 1820 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 157891 | 51.5794 | 1820 |
| 157890 | 1.9919 | 1160 |
Top tissues by expression
134 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| granulocyte | CL:0000094 | 95.03 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 94.99 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 94.92 | gold quality |
| apex of heart | UBERON:0002098 | 94.61 | gold quality |
| leukocyte | CL:0000738 | 94.39 | gold quality |
| monocyte | CL:0000576 | 94.34 | gold quality |
| islet of Langerhans | UBERON:0000006 | 94.16 | gold quality |
| right lobe of liver | UBERON:0001114 | 93.96 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 93.72 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 93.05 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 93.03 | gold quality |
| fallopian tube | UBERON:0003889 | 92.97 | gold quality |
| right uterine tube | UBERON:0001302 | 92.91 | gold quality |
| pancreas | UBERON:0001264 | 92.87 | gold quality |
| spleen | UBERON:0002106 | 92.65 | gold quality |
| body of stomach | UBERON:0001161 | 92.56 | gold quality |
| left adrenal gland | UBERON:0001234 | 92.51 | gold quality |
| metanephros cortex | UBERON:0010533 | 92.51 | gold quality |
| body of pancreas | UBERON:0001150 | 92.48 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 92.42 | gold quality |
| right testis | UBERON:0004534 | 92.41 | gold quality |
| stromal cell of endometrium | CL:0002255 | 92.40 | gold quality |
| prostate gland | UBERON:0002367 | 92.39 | gold quality |
| right adrenal gland | UBERON:0001233 | 92.28 | gold quality |
| fundus of stomach | UBERON:0001160 | 92.23 | gold quality |
| lymph node | UBERON:0000029 | 92.18 | gold quality |
| liver | UBERON:0002107 | 92.14 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 92.10 | gold quality |
| left testis | UBERON:0004533 | 92.05 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 92.04 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.69 |
Regulation
Is transcription factor: no
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 57.0% of screened cell lines.
Literature-anchored findings (GeneRIF, showing 3)
- hCTF18, hCTF8, and hDCC1 interact with each other as well as with the p38 subunit of RFC (PMID:12766176)
- The alternative Ctf18-Dcc1-Ctf8-replication factor C complex required for sister chromatid cohesion loads proliferating cell nuclear antigen onto DNA. (PMID:12930902)
- Stable interaction between the human proliferating cell nuclear antigen loader complex Ctf18-replication factor C (RFC) and DNA polymerase {epsilon} is mediated by the cohesion-specific subunits, Ctf18, Dcc1, and Ctf8. (PMID:20826785)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | chtf8 | ENSDARG00000069045 |
| mus_musculus | Chtf8 | ENSMUSG00000046691 |
| drosophila_melanogaster | CG34001 | FBGN0054001 |
| caenorhabditis_elegans | ctf-8 | WBGENE00011915 |
Protein
Protein identifiers
Chromosome transmission fidelity protein 8 homolog — P0CG13 (reviewed: P0CG13)
All UniProt accessions (5): P0CG13, E5RGY5, E5RHL4, H3BQB7, J3KSJ7
UniProt curated annotations — full annotation on UniProt →
Function. Chromosome cohesion factor involved in sister chromatid cohesion and fidelity of chromosome transmission. Component of one of the cell nuclear antigen loader complexes, CTF18-replication factor C (CTF18-RFC), which consists of CTF18, CTF8, DSCC1, RFC2, RFC3, RFC4 and RFC5. The CTF18-RFC complex binds to single-stranded and primed DNAs and has weak ATPase activity that is stimulated the presence of primed DNA, replication protein A (RPA) and proliferating cell nuclear antigen (PCNA). The CTF18-RFC complex catalyzes the ATP-dependent loading of PCNA onto primed and gapped DNA. It also interacts with and stimulates POLH, which is suggestive of a protein network that coordinates DNA repair, recombination and chromosome cohesion reactions with replication fork progression.
Subunit / interactions. Component of the CTF18-RFC complex, which consists of CTF18, CTF8, DSCC1, RFC2, RFC3, RFC4 and RFC5. The CTF18-RFC complex does not interact with the Rad9/Rad1/Hus1 complex. The CTF18-RFC complex interacts with POLH. CTF18/CTF8/DSCC1 associate with PCNA. CTF8 exists as a dimer with DSCC1.
Subcellular location. Nucleus.
Similarity. Belongs to the CTF8 family.
RefSeq proteins (2): NP_001034779, NP_001035236 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR018607 | Ctf8 | Family |
Pfam: PF09696
UniProt features (1 total): chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P0CG13-F1 | 86.99 | 0.61 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-174411 | Polymerase switching on the C-strand of the telomere |
MSigDB gene sets: 123 (showing top):
GOBP_CHROMOSOME_ORGANIZATION, GOBP_POSITIVE_REGULATION_OF_DNA_BIOSYNTHETIC_PROCESS, chr16q22, GOBP_REGULATION_OF_TRANSFERASE_ACTIVITY, GOBP_POSITIVE_REGULATION_OF_CATALYTIC_ACTIVITY, GOBP_POSITIVE_REGULATION_OF_MOLECULAR_FUNCTION, GOBP_SISTER_CHROMATID_COHESION, GOBP_DNA_BIOSYNTHETIC_PROCESS, REACTOME_EXTENSION_OF_TELOMERES, GOBP_REGULATION_OF_DNA_BIOSYNTHETIC_PROCESS, RASHI_RESPONSE_TO_IONIZING_RADIATION_5, GOBP_DNA_REPLICATION, GOBP_MITOTIC_SISTER_CHROMATID_COHESION, GOBP_CELL_CYCLE_PROCESS, GOBP_DNA_METABOLIC_PROCESS
GO Biological Process (3): DNA replication (GO:0006260), mitotic sister chromatid cohesion (GO:0007064), positive regulation of DNA-directed DNA polymerase activity (GO:1900264)
GO Molecular Function (4): DNA binding (GO:0003677), DNA clamp loader activity (GO:0003689), protein binding (GO:0005515), single-stranded DNA helicase activity (GO:0017116)
GO Cellular Component (3): nucleoplasm (GO:0005654), Ctf18 RFC-like complex (GO:0031390), nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Telomere C-strand (Lagging Strand) Synthesis | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| DNA metabolic process | 1 |
| DNA biosynthetic process | 1 |
| sister chromatid cohesion | 1 |
| DNA-directed DNA polymerase activity | 1 |
| positive regulation of catalytic activity | 1 |
| regulation of transferase activity | 1 |
| positive regulation of DNA biosynthetic process | 1 |
| nucleic acid binding | 1 |
| DNA binding | 1 |
| ATP-dependent activity, acting on DNA | 1 |
| binding | 1 |
| DNA helicase activity | 1 |
| nuclear lumen | 1 |
| cellular anatomical structure | 1 |
| chromosome | 1 |
| nuclear protein-containing complex | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
708 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CHTF8 | CHTF18 | Q8WVB6 | 999 |
| CHTF8 | DSCC1 | Q9BVC3 | 999 |
| CHTF8 | RFC2 | P32846 | 989 |
| CHTF8 | RFC5 | P40937 | 978 |
| CHTF8 | RFC3 | P40938 | 970 |
| CHTF8 | SMC3 | Q9UQE7 | 910 |
| CHTF8 | RFC4 | P35249 | 909 |
| CHTF8 | ESCO1 | Q5FWF5 | 878 |
| CHTF8 | WAPL | Q7Z5K2 | 849 |
| CHTF8 | WDHD1 | O75717 | 838 |
| CHTF8 | PDS5A | Q29RF7 | 832 |
| CHTF8 | ESCO2 | Q56NI9 | 822 |
| CHTF8 | RAD21 | O60216 | 732 |
| CHTF8 | ATAD5 | Q96QE3 | 723 |
| CHTF8 | RAD17 | O75943 | 672 |
IntAct
27 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| PSMC3 | PSMD9 | psi-mi:“MI:0914”(association) | 0.940 |
| RFC5 | RAD17 | psi-mi:“MI:0914”(association) | 0.730 |
| RFC4 | RAD17 | psi-mi:“MI:0914”(association) | 0.730 |
| CHTF8 | IL36A | psi-mi:“MI:0915”(physical association) | 0.670 |
| DSCC1 | CHTF8 | psi-mi:“MI:0914”(association) | 0.530 |
| FKBP9 | CASC3 | psi-mi:“MI:0914”(association) | 0.530 |
| CHTF8 | AP4M1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| FKBP9 | COL2A1 | psi-mi:“MI:0914”(association) | 0.350 |
| PPIE | PLRG1 | psi-mi:“MI:0914”(association) | 0.350 |
| RFC4 | RAD1 | psi-mi:“MI:0914”(association) | 0.350 |
| IL36A | RNF40 | psi-mi:“MI:0914”(association) | 0.350 |
| RFC5 | RAD17 | psi-mi:“MI:0914”(association) | 0.350 |
| KCTD12 | DUSP11 | psi-mi:“MI:0914”(association) | 0.350 |
| CHTF18 | ALDOB | psi-mi:“MI:0914”(association) | 0.350 |
| CPNE2 | SUPT5H | psi-mi:“MI:0914”(association) | 0.350 |
| KCTD12 | CYTH3 | psi-mi:“MI:0914”(association) | 0.350 |
| RFC4 | A2ML1 | psi-mi:“MI:0914”(association) | 0.350 |
| FHIP2A | MED19 | psi-mi:“MI:2364”(proximity) | 0.270 |
BioGRID (48): CHTF8 (Affinity Capture-RNA), CHTF8 (Affinity Capture-RNA), CHTF8 (Affinity Capture-MS), CHTF8 (Affinity Capture-MS), CHTF8 (Affinity Capture-MS), CHTF8 (Two-hybrid), RFC3 (Affinity Capture-Western), CHTF8 (Proximity Label-MS), CHTF8 (Affinity Capture-MS), CHTF8 (Affinity Capture-MS), CHTF8 (Affinity Capture-MS), CHTF8 (Affinity Capture-MS), CHTF8 (Affinity Capture-MS), CHTF8 (Affinity Capture-MS), CHTF8 (Affinity Capture-MS)
ESM2 similar proteins: D3ZLY0, O08848, O35473, O95453, P0C6T1, P0CG11, P0CG13, P0CG15, P0CL18, P13984, P41214, P50747, P69341, Q01750, Q03123, Q05B58, Q13901, Q15650, Q2T9L9, Q2T9Y1, Q32PE4, Q3U2J5, Q5PPG7, Q5RA63, Q5RBU4, Q5RC51, Q5RK19, Q5U3V9, Q5ZHS3, Q6DC64, Q6GR37, Q6NYU2, Q6P4H8, Q7TSU0, Q80YV4, Q8BY71, Q8IVD9, Q8K2Q0, Q8R0A0, Q8R1T1
Diamond homologs: P0C6T1, P0CG11, P0CG13, P0CG15
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
23 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 18 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
568 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 16:69121166:TCGCA:T | acceptor_gain | 1.0000 |
| 16:69121167:CGCA:C | acceptor_gain | 1.0000 |
| 16:69121167:CGCAC:C | acceptor_gain | 1.0000 |
| 16:69121168:GCA:G | acceptor_gain | 1.0000 |
| 16:69121169:CA:C | acceptor_gain | 1.0000 |
| 16:69121169:CAC:C | acceptor_gain | 1.0000 |
| 16:69121170:ACTG:A | acceptor_loss | 1.0000 |
| 16:69121171:C:CA | acceptor_loss | 1.0000 |
| 16:69121171:C:CC | acceptor_gain | 1.0000 |
| 16:69121431:CTTA:C | donor_loss | 1.0000 |
| 16:69121432:TTA:T | donor_loss | 1.0000 |
| 16:69121433:TA:T | donor_loss | 1.0000 |
| 16:69121434:ACC:A | donor_loss | 1.0000 |
| 16:69121435:C:CG | donor_loss | 1.0000 |
| 16:69121489:ACAAG:A | acceptor_gain | 1.0000 |
| 16:69121490:CAAG:C | acceptor_gain | 1.0000 |
| 16:69121490:CAAGC:C | acceptor_gain | 1.0000 |
| 16:69121491:AAG:A | acceptor_gain | 1.0000 |
| 16:69121492:AG:A | acceptor_gain | 1.0000 |
| 16:69121492:AGC:A | acceptor_loss | 1.0000 |
| 16:69121493:GC:G | acceptor_loss | 1.0000 |
| 16:69121494:C:CC | acceptor_gain | 1.0000 |
| 16:69121494:C:T | acceptor_loss | 1.0000 |
| 16:69121495:T:A | acceptor_loss | 1.0000 |
| 16:69120649:CCTT:C | acceptor_gain | 0.9900 |
| 16:69121048:CTCA:C | donor_loss | 0.9900 |
| 16:69121051:A:T | donor_loss | 0.9900 |
| 16:69121052:C:CT | donor_loss | 0.9900 |
| 16:69121430:ACTT:A | donor_loss | 0.9900 |
| 16:69121434:A:AC | donor_gain | 0.9900 |
AlphaMissense
774 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 16:69120473:G:C | F106L | 0.996 |
| 16:69120473:G:T | F106L | 0.996 |
| 16:69120474:A:G | F106S | 0.996 |
| 16:69120475:A:G | F106L | 0.996 |
| 16:69120609:C:T | G61E | 0.996 |
| 16:69120610:C:A | G61W | 0.996 |
| 16:69120576:A:T | V72D | 0.995 |
| 16:69120609:C:A | G61V | 0.995 |
| 16:69120463:G:A | P110S | 0.994 |
| 16:69120462:G:T | P110H | 0.993 |
| 16:69120499:C:G | A98P | 0.993 |
| 16:69120627:C:T | G55E | 0.993 |
| 16:69120636:A:G | L52P | 0.993 |
| 16:69120615:A:G | L59P | 0.992 |
| 16:69120627:C:A | G55V | 0.992 |
| 16:69121124:C:G | G24R | 0.992 |
| 16:69121124:C:T | G24R | 0.992 |
| 16:69120475:A:C | F106V | 0.991 |
| 16:69120475:A:T | F106I | 0.991 |
| 16:69120579:G:T | A71E | 0.991 |
| 16:69121075:C:T | G40E | 0.991 |
| 16:69120463:G:T | P110T | 0.990 |
| 16:69120466:G:T | R109S | 0.989 |
| 16:69120482:C:A | K103N | 0.988 |
| 16:69120482:C:G | K103N | 0.988 |
| 16:69121129:A:G | L22P | 0.988 |
| 16:69121076:C:G | G40R | 0.987 |
| 16:69121076:C:T | G40R | 0.987 |
| 16:69121123:C:T | G24E | 0.987 |
| 16:69120610:C:G | G61R | 0.986 |
dbSNP variants (sampled 300 via entrez): RS1000311617 (16:69119977 G>A,C), RS1000537458 (16:69130925 T>C), RS1000769290 (16:69130528 C>A), RS1000915406 (16:69134408 G>C), RS1001210112 (16:69122032 C>A,T), RS1001282816 (16:69125686 A>C,G), RS1001868649 (16:69125805 G>A,C), RS1001898988 (16:69131595 C>A,G), RS1002171595 (16:69129710 TCTC>T), RS1002359386 (16:69126055 A>G), RS1002374308 (16:69131869 A>T), RS1002433966 (16:69117915 G>A), RS1002568418 (16:69134182 G>A), RS1002621283 (16:69120871 T>C), RS1002887875 (16:69118625 T>C)
Disease associations
OMIM: gene MIM:613202 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST005951_13 | Body mass index | 5.000000e-11 |
| GCST010703_183 | Brain morphology (MOSTest) | 5.000000e-11 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004340 | body mass index |
| EFO:0004346 | neuroimaging measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
27 total (human), top 27 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | affects cotreatment, increases methylation, decreases expression | 2 |
| Valproic Acid | affects expression, decreases expression | 2 |
| GSK-J4 | decreases expression | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | decreases expression | 1 |
| sodium arsenite | affects cotreatment, decreases expression, increases abundance | 1 |
| butyraldehyde | decreases expression | 1 |
| manganese chloride | affects cotreatment, decreases expression, increases abundance | 1 |
| ferrous chloride | decreases expression | 1 |
| pentanal | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| 2,3,5-(triglutathion-S-yl)hydroquinone | increases ADP-ribosylation | 1 |
| 14-deoxy-11,12-didehydroandrographolide | decreases expression | 1 |
| abrine | increases expression | 1 |
| 7-(benzylamino)-1,3,4,8-tetrahydropyrrolo(4,3,2-de)quinolin-8(1H)-one | decreases expression | 1 |
| Fulvestrant | affects cotreatment, increases methylation | 1 |
| Leflunomide | decreases expression | 1 |
| Air Pollutants, Occupational | decreases expression | 1 |
| Arsenic | affects cotreatment, decreases expression, increases abundance | 1 |
| Atrazine | increases expression | 1 |
| Doxorubicin | increases expression | 1 |
| Ivermectin | decreases expression | 1 |
| Manganese | affects cotreatment, decreases expression, increases abundance | 1 |
| Nickel | decreases expression | 1 |
| Quercetin | increases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Cyclosporine | decreases expression | 1 |
| Lactic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.